Emergent BioSolutions (EBS) Gross Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted Gross Margin of 58.56% for Q2 2026, up 8.69% on a QoQ basis from 53.88% in Q1 2026, and up 604.0% year-over-year from 8.32% in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Gross Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Gross Margin for 16 years, with the latest figure at 58.56% in Q2 2026.
- On a quarterly basis, Gross Margin rose 604.0% year-over-year to 58.56% in Q2 2026; TTM through Jun 2026 was 55.87%, a 237.0% increase from a year earlier, with the FY2025 full-year figure at 56.09%, up 2137.0% from the prior year.
- Gross Margin was 58.56% for Q2 2026 at Emergent BioSolutions, up from 53.88% in the prior quarter.
- The five-year high for Gross Margin was 62.83% in Q3 2025, with the low at 16.25% in Q2 2024.
- Average Gross Margin over 5 years is 41.61%, with a median of 46.22% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Gross Margin plunged 5985 bps in 2024, then surged 6877 bps in 2025.
- Over 5 years, Gross Margin stood at 49.18% in 2022, then slumped by 33 bps to 33.08% in 2023, then rose by 19 bps to 39.39% in 2024, then rose by 9 bps to 42.91% in 2025, then surged by 36 bps to 58.56% in 2026.
- The last three Gross Margin figures came in at 58.56% (Q2 2026), 53.88% (Q1 2026), and 42.91% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 78.02% |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 72.78% |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 71.28% |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 80.05% |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 89.76% |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 58.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.56% |
| Mar 31, 2026 | 53.88% |
| Dec 31, 2025 | 42.91% |
| Sep 30, 2025 | 62.83% |
| Jun 30, 2025 | 52.52% |
| Mar 31, 2025 | 60.17% |
| Dec 31, 2024 | 39.39% |
| Sep 30, 2024 | 58.27% |
| Jun 30, 2024 | -16.25% |
| Mar 31, 2024 | 51.86% |
| Dec 31, 2023 | 33.08% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 43.59% |
| Mar 31, 2023 | 6.94% |
| Dec 31, 2022 | 49.18% |
| Sep 30, 2022 | 38.64% |
| Jun 30, 2022 | 30.01% |
| Mar 31, 2022 | 48.85% |
| Dec 31, 2021 | 80.22% |
| Sep 30, 2021 | 60.08% |
API Access
Emergent BioSolutions Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();